Published in PLoS One on August 26, 2011
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity. Science (2016) 1.52
PD-L1 expression is increased in a subset of basal type breast cancer cells. PLoS One (2014) 1.46
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery. Int J Parasitol Drugs Drug Resist (2014) 0.80
NLS-tagging: an alternative strategy to tag nuclear proteins. Nucleic Acids Res (2014) 0.77
Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB. PLoS One (2013) 0.75
SMAD transcription factors are altered in cell models of HD and regulate HTT expression. Cell Signal (2016) 0.75
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell (2006) 20.92
A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A (2008) 10.07
Nuclear envelope permeability. Nature (1975) 9.29
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature (2005) 5.50
Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Cell (1991) 5.17
Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell (2006) 3.44
Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell (2009) 3.03
Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal (2009) 2.92
Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A (1999) 2.58
Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics (2009) 2.49
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci (2005) 1.85
Nuclear import of histone H2A and H2B is mediated by a network of karyopherins. J Cell Biol (2001) 1.79
Differential modes of nuclear localization signal (NLS) recognition by three distinct classes of NLS receptors. J Biol Chem (1997) 1.60
Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal. J Biol Chem (2005) 1.35
ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation. J Biol Chem (2009) 1.31
Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl Acad Sci U S A (2000) 1.29
MCAT elements and the TEF-1 family of transcription factors in muscle development and disease. Arterioscler Thromb Vasc Biol (2007) 1.27
Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res (2003) 1.25
Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis. J Clin Invest (2007) 1.15
Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes. J Biol Chem (2004) 1.14
Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J Proteome Res (2008) 1.09
Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis (2010) 1.04
A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Mol Cell Biol (2011) 1.01
IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J (2010) 1.00
MOS11: a new component in the mRNA export pathway. PLoS Genet (2010) 0.99
A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation. J Cell Biol (2007) 0.96
The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res (2008) 0.92
Protein kinase C-related kinase targets nuclear localization signals in a subset of class IIa histone deacetylases. FEBS Lett (2010) 0.92
Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Res (2009) 0.91
Identification of a nuclear localization signal in suppressor of cytokine signaling 1. FASEB J (2008) 0.90
Nuclear localization signal and phosphorylation of Serine350 specify intracellular localization of DRAK2. J Biochem (2007) 0.84
Crystallization and preliminary X-ray diffraction analysis of importin-alpha complexed with NLS peptidomimetics. Biochim Biophys Acta (2005) 0.79
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med (2006) 3.59
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet (2010) 3.15
Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol (2010) 3.07
Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol (2009) 2.79
Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med (2011) 2.29
A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet (2009) 2.09
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med (2010) 1.75
Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. J Am Coll Cardiol (2009) 1.64
Blood pressure loci identified with a gene-centric array. Am J Hum Genet (2011) 1.44
Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet (2012) 1.35
Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J Biol Chem (2002) 1.35
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet (2012) 1.35
Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. Circ Res (2009) 1.33
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med (2012) 1.27
Genes and coronary artery disease: where are we? J Am Coll Cardiol (2012) 1.25
Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circ Cardiovasc Genet (2010) 1.23
Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ Res (2006) 1.20
TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun (2002) 1.16
Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype. J Am Coll Cardiol (2012) 1.15
Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes. J Biol Chem (2004) 1.14
Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol (2012) 1.10
Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler Thromb Vasc Biol (2011) 1.10
Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation (2004) 1.08
Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genomics (2004) 1.08
Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol (2014) 1.08
Transcription cofactor Vgl-2 is required for skeletal muscle differentiation. Genesis (2004) 1.06
IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J (2010) 1.00
Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies. Clin Cancer Res (2004) 0.96
LMO4 mRNA stability is regulated by extracellular ATP in F11 cells. Biochem Biophys Res Commun (2007) 0.96
Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc (2015) 0.96
Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4. J Neurosci (2008) 0.95
9p21 and the genetic revolution for coronary artery disease. Clin Chem (2011) 0.94
Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes. J Biol Chem (2002) 0.93
The genetics of coronary artery disease. Curr Opin Cardiol (2012) 0.92
The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies. Hum Genet (2009) 0.92
Differential expression of a transcription regulatory factor, the LIM domain only 4 protein Lmo4, in muscle sensory neurons. Development (2002) 0.91
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet (2013) 0.90
Loss of LMO4 in the retina leads to reduction of GABAergic amacrine cells and functional deficits. PLoS One (2010) 0.90
Identifying genes for coronary artery disease: An idea whose time has come. Can J Cardiol (2007) 0.90
Genomics in coronary artery disease: past, present and future. Can J Cardiol (2010) 0.88
Alpha(1)-adrenergic activation of the cardiac ankyrin repeat protein gene in cardiac myocytes. Gene (2002) 0.88
The genome-wide association study--a new era for common polygenic disorders. J Cardiovasc Transl Res (2010) 0.87
RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies. PLoS One (2011) 0.87
Tail-anchored membrane protein SLMAP is a novel regulator of cardiac function at the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol (2011) 0.87
Troponin I protein kinase C phosphorylation sites and ventricular function. Cardiovasc Res (2004) 0.87
Extracellular ATP-dependent upregulation of the transcription cofactor LMO4 promotes neuron survival from hypoxia. Exp Cell Res (2007) 0.86
LIM domain only 4 (LMO4) regulates calcium-induced calcium release and synaptic plasticity in the hippocampus. J Neurosci (2012) 0.85
Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss. FASEB J (2009) 0.84
The LIM domain only 4 protein is a metabolic responsive inhibitor of protein tyrosine phosphatase 1B that controls hypothalamic leptin signaling. J Neurosci (2013) 0.84
Identification of a novel muscle A-type lamin-interacting protein (MLIP). J Biol Chem (2011) 0.84
Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. Arterioscler Thromb Vasc Biol (2015) 0.83
Two chromosome 9p21 haplotype blocks distinguish between coronary artery disease and myocardial infarction risk. Circ Cardiovasc Genet (2013) 0.83
Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity. Oncotarget (2012) 0.83
Genomics in cardiovascular disease. J Am Coll Cardiol (2013) 0.83
Functional genomics of the 9p21.3 locus for atherosclerosis: clarity or confusion? Curr Cardiol Rep (2014) 0.81
Genetics of coronary artery disease in the 21st century. Clin Cardiol (2012) 0.81
LIM domain only 4 protein promotes granulocyte colony-stimulating factor-induced signaling in neurons. Cell Mol Life Sci (2009) 0.81
TEF-1 transcription factors regulate activity of the mouse mammary tumor virus LTR. Biochem Biophys Res Commun (2002) 0.80
Recent success in the discovery of coronary artery disease genes. Can J Physiol Pharmacol (2011) 0.79
LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia. J Neurosci (2014) 0.78
Making sense of genome-wide association studies: integrating genetic variation with gene expression to derive functional mechanisms underlying disease risk. Circulation (2014) 0.76
From genes to regenerative medicine: approaches in development. Circ Res (2008) 0.75
Ablation of LMO4 in glutamatergic neurons impairs leptin control of fat metabolism. Cell Mol Life Sci (2011) 0.75
Lack of association of chromosome 9p21.3 genotype with cardiovascular function in persons with stable coronary artery disease: The heart and soul study. Atherosclerosis (2009) 0.75
Mouse viruses and human disease. Lancet Infect Dis (2011) 0.75
Genomics: is it ready for primetime? Med Clin North Am (2012) 0.75
Characterization of cardiac gene promoter activity: reporter constructs and heterologous promoter studies. Methods Mol Biol (2007) 0.75